CUE icon

Cue Biopharma

63 hedge funds and large institutions have $168M invested in Cue Biopharma in 2019 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$29.7M
2 +$9.55M
3 +$4.29M
4
PM
Precept Management
Texas
+$2.7M
5
BlackRock
BlackRock
New York
+$2.64M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$29.7M
2
$22.3M
3
$22M
4
$14.1M
5
$14.1M
6
$9.55M
7
$5.3M
8
$5.08M
9
$4.52M
10
$4.29M
11
$4.18M
12
$3.49M
13
$2.7M
14
$2.62M
15
$2.19M
16
$2.08M
17
$1.47M
18
$1.47M
19
$1.21M
20
$1.14M
21
$1.05M
22
$1.04M
23
$937K
24
$933K
25
$887K